Objective: To assess the clinical course and genotype-phenotype correlations in patients with selenoprotein-related myopathy (SEPN1-RM) due to selenoprotein N1 gene (SEPN1) mutations for a retrospective cross-sectional study.
genotype and clinical course or pathologic findings. 3, 4, 13 Although the precise function of SEPN1 protein is uncertain, recent studies suggest a role in the physiologic redox-related calcium homeostasis and cell protection against oxidative stress. 14, 15 While SEPN1 mutations in patients with the various histopathologic phenotypes 2, 4, 5, 13, 16 have been described, no systematic study correlating these findings in a large cohort of SEPN1-RM patients has been reported.
In this study, we investigated the clinical course and genotype-phenotype correlations in 41 SEPN1-RM patients, including children, adolescents, and adults, focusing on the age at presentation, functional mobility impairment, and major events such as age when respiratory support was initiated, respiratory involvement, spinal surgery, and survival.
METHODS This was a retrospective cross-sectional study of 41 patients with molecularly confirmed SEPN1-RM. Data were collected by reviewing the case notes of patients followed at the Dubowitz Neuromuscular Centre in London, United Kingdom (18/41), or from other centers who referred muscle biopsy or DNA samples to our National Commissioning Group service and provided clinical information using a structured questionnaire (23/41). Follow-up data were provided by the referring clinicians involved.
The following data were collected: age at presentation, maximal serum CK level documented, mobility and motor functional ability at the time of the survey, presence or absence of rigidity of the spine and other contractures, presence and severity of scoliosis and age at spinal surgery if performed, respiratory function including forced vital capacity (FVC) measurement and results of overnight oxygen saturation monitoring studies, the age at initiation of nocturnal noninvasive ventilation (NIV), weight gain, heart function, survival, muscle biopsy features, and genetic analysis. Respiratory intervention with nocturnal NIV was established following clinical evaluation together with the evidence of nocturnal hypercarbia. 17 Genetic analysis. Genomic DNA was extracted from peripheral blood leukocytes according to standard procedures and the SEPN1 exons were sequenced from genomic DNA. Mutations are listed in Onset of symptoms. The mean age at onset of symptoms was 2.7 years (median 1.5, SD 3.2), ranging from birth to the second decade. Fifteen patients (36.5%) had a congenital presentation with a variable combination of hypotonia (11/15), torticollis (1/15), feeding difficulties (2/15), and recurrent chest infections (1/15). In 19 patients (46%), the presentation was between 6 months and 5 years of age with delayed motor milestones or gross motor difficulties, subdivided in the following categories: 8/19 (42%) delayed ability to sit unsupported, 6/19 (31.5%) delayed walking (after 18 months of age), and 5/19 (26%) presented with difficulty running or frequent falls. In 3 patients (7.3%), the presentation was between 6 to 10 years of age with scoliosis (1/3), or easy fatigability (2/3). Another 2 patients were first referred at the age of 7 years for walking and running difficulties. Two patients (4.8%) presented at 13 years of age with back stiffness and general muscle wasting with weakness. Creatine kinase. CK serum level was available in 37/41 patients and was within the normal range (upper level 150 U/L) in 29/37 (73%), minimally elevated (range 156 -283 U/L) in 6/37 (16%), and markedly elevated (1,400 U/L at 8 years) in one patient (patient 7, table e-1). Another patient, a 5-year-old girl (patient 40, table e-1), had a value of 2,459 UI/L but she was also a Duchenne muscular dystrophy carrier, with a nonsense mutation in the dystrophin gene (c.2348AϾC).
Functional abilities. All patients acquired independent ambulation. All but 2 patients remain fully ambulant and able to walk independently indoors and outdoors. However, one patient became wheelchair-dependent in his late 50s, 4 patients required a wheelchair for long distances, and one patient aged 5 years needed help to self stand and take few steps. Despite the presence of motor difficulties such as climbing stairs in 24 of 39 (62%) ambulant cases, functional abilities did not deteriorate during follow-up in most patients of our cohort (85% of cases) (tables e-1 and e-2). Joint contractures. Joint contractures were present in 26 patients (63%) at a mean age of 10.4 years (median 8 and SD 7.2); Achilles tendon (17/25) and elbow (12/25) contractures were most commonly observed, followed by long finger flexor contractures.
Two patients had finger contractures at birth; in 7 patients distal laxity was noted together with joint contractures. In 2 patients isolated distal joint laxity was a prominent feature.
Respiratory function. FVC data were available from 26 patients older than 5 years. The figure, A, shows the correlation between FVC% with increasing age. All patients except one had FVC values below 80% of that predicted for height. The linear correlation showed a drop of FVC of 1.1% per year (95% confidence interval [CI] 0.12-2.1), p ϭ 0.029. Individual values and the 95% CI are given in the figure, A.
Data on overnight oxygen saturation studies were available in 37/41 cases. In 32 of the 37 (86%), some abnormalities were found at a mean age of 13.2 years (median 13.2; SD 6.5), requiring nocturnal NIV in 27/32, at a mean age of 13.9 years (median 14; SD 7). Of the 4 cases without a sleep study result, 3 declined scheduled regular respiratory follow-up (patients 21, 33, and 36; table e-1), and in the remaining one the study is awaited (patient 30; table e-1).
The need for nocturnal NIV increased with age, as at the age of 15 years 50% of cases needed ventilatory support, while at 20 years the need of ventilatory support was increased to 75% of cases (figure, B). The youngest ventilated patient was aged 1 year and 2 other patients required ventilation at the age of 5 years (in one of them the first abnormal sleep study was documented at the age of 4). Two patients (4.8%) were not ventilated in the fourth decade (patients 1 and 3; table e-1). The mean FVC value when starting NIV was 29.6% (SD 10.8). There was no apparent increased dependency on NIV with age.
Spine. Scoliosis developed in 28 patients (70%) at a mean age of 10.2 years (median 10; SD 3.8); in 4/28, it developed before 5 years, but 14/28 (50%) patients were older than 10 years. In most cases, rigidity of the spine preceded the scoliosis, with a mean age at onset of 8.6 years (median 8; SD 4.3). Spinal surgery was proposed when patients had a progressive curvature in which Cobb angle exceeded 50 degrees. 18 A spinal fusion was performed in 14 patients (34%) at a mean age of 13.9 years (median 14.9; SD 3.7) with only one child requiring surgery at the age of 3 years. The duration of follow-up postsurgery ranged between 1 and 26 years (mean 7.9). All the operated patients remained fully ambulant after the surgery with the exception of the one operated at 3 years who required a wheelchair for long distances at the age of 11 years. In 5/14 operated cases (36%), a temporary improvement of the FVC was noted about 6 months to 1 year after surgery, with a mean FVC improvement of 11% (SD 5.4).
Cardiac involvement. Thirty-two of 41 patients underwent cardiac assessment and 27/32 had normal ECG and echocardiogram (84%), although mild right ventricular hypertrophy/mild pulmonary hypertension was found in the remaining 5 patients (16%).
Weight gain. Weight measurement was available in 35 patients. Twenty of the 35 (57%) were underweight (Ͻ3rd percentile) and 3 (8.5%) were above the 97th centile. Those patients with the lowest weight percentile subsequently followed this centile with no drop in growth velocity. There was no obvious association between weight and level of ability. None reported significant feeding difficulties but one patient (patient 27, table e-1) required gastrostomy with fundoplication for gastroesophageal reflux at the age of 1 year. Three cases (patients 9, 25, and 30, table e-1) were prescribed food supplements, which resulted in effective weight maintenance.
Survival. Two patients died from respiratory failure at the age of 10 years and 22 years. The first patient (patient 21, table e-1) was a girl with obesity and hepatic steatosis who failed to attend her scheduled respiratory follow-up despite her FVC being abnormal at 36% at the age of 10 years. The second patient (patient 33, table e-1) declined the scheduled regular respiratory follow-up and died suddenly at home at the age of 22 years. A postmortem examination showed a mild right ventricular hypertrophy.
Muscle biopsy. A muscle biopsy was performed in 34/41 patients. The main histologic changes, reported by our pathologist in 10/34 cases and by the referring pathologists in the remaining cases (table e-1), included cores/multiminicores (19/34, 55% of cases, in association with marked fibrosis in 1 case); nonspecific myopathic changes in 8 cases (24%), including 2 cases with excess fibrosis, one of whom was also a carrier of Duchenne muscular dystrophy; type 1 predominance in 7/34 (21%) patients including one case presenting in association with minicores; the presence of Mallory bodies was reported in one patient.
Genetic analysis. Genomic sequencing revealed 14 previously undescribed SEPN1 mutations. The distribution of mutations is shown in table e-1; 48% are missense, 18% splice site, 28% small deletions/insertions including a 92-bp deletion extending from exon1 in the 5ЈUTR. We observed a cluster of mutations in exons 1, 6, 7, and 10. Twenty-one of 41 patients carried a homozygous mutation; the remaining 20 were compound heterozygous for the identified mutations. Two patients (patients 11 and 19, table e-1) had in compound heterozygous state the c.1397 GϾA mutation in the selenocysteine redefinition element (SRE). 8 The selenocysteine incorporation codon which is located in exon 10 may also be involved in 4 additional patients (patients 4, 5, 12, and 23, table e-1), who have splice site mutations at the splice donor site of exon 9. Although the effect of splice site mutations needs to be verified by RNA analysis, these mutations are most likely to affect the splicing of exon 10 and induce a frameshift. Several patients with homozygous mutations affecting the SEPN1 start codon, in whom no SEPN1 is predicted to be produced, have relatively mild phenotypes (cases 2, 7, 16, 26, and 39); however 2 individuals (29 and 37) are more severely affected, needing a wheelchair for long distances (table e-1). We did not observe a clear correlation between genotype and phenotype, including the muscle biopsy findings. The c.943 GϾA mutation described before 4, 7, 19 was present in 11 patients. DISCUSSION SEPN1 mutations in patients with rigid spine have been described in association with dystrophic changes on muscle biopsy since 1998 and subsequently with multiminicores, congenital fiber type disproportion, and Mallory-bodies inclusions in several studies. 2, 4, 5, 13, 16 Most of the previous studies reported few patients associated with each of these forms and showed remarkable clinical homogeneity. 2, 4, 5, 13, 16 The age of the patients reported so far ranged between 1 and 41 years. [1] [2] [3] [4] 13, 19, 20 In the present study, we report a larger number of patients with SEPN1-RM of wider age range, irrespective of the clinicopathologic phenotype. Our cross-sectional data provide additional information on the spectrum of clinical features in this condition. In agreement with previous studies, 2,3,5,14 we found that in most patients the onset of clinical signs was in the first few years of life, with 19 of them having delayed milestones or gross motor difficulties detected before the age of 5 years. In a minority of cases, however (2/41), there was no concern until the second decade of life.
With few exceptions, all our patients maintained ambulation. Of the 3 cases who were older than 40, all remained ambulant and fully active with the exception of one case who needed a wheelchair for outdoors in the sixth decade followed by progression of weakness in the late 50s. Few patients (9.7%) had difficulties walking outdoors for long distances; this occurred in the first decade (2 cases) and in the second decade (2 more cases), due to progressive scoliosis and weakness without specific precipitating factors. Only one patient (patient 27, table e-1), with a congenital presentation, was unable to walk without help at 5 years, while several other patients with congenital onset were fully ambulant in adulthood, suggesting that the clinical course severity is independent of the age at onset. Joint contractures were found in most cases (63%), most commonly in Achilles tendons and elbows and less frequently in the long finger flexors. As previously noted, contractures are neither a presenting feature 2-4 nor a significantly progressive factor in the condition, with the exception of the spinal rigidity. Scoliosis was frequent (70%), developing at a mean age of 10.2 years, often proceeded by spinal rigidity. As a result of severe scoliosis, about onethird of the patients had a spinal fusion at a mean age of 13.9 years (table e-1); the surgery was well tolerated in all of them with no deterioration of motor or respiratory function after surgery.
FVC values were abnormal in all patients, except one around 8 years, from the age of 5 years, which is the earliest age at which FVC can be reliably measured in our experience. Sleep studies were found to be abnormal at a mean age of 13.2 years, anticipating the need for nocturnal NIV, which became necessary in 66% of our patients during the second decade of life at a mean age of 13.9 years. It is of note that in 2 patients abnormal nocturnal oxygen saturation mon-itoring was present as early as 2 and 4 years of age, respectively, suggesting that sleep studies should be performed regularly even in young children. At the other end of the spectrum, 2 patients started nocturnal NIV only at the age of 33 years after an episode of acute respiratory failure. Such a delayed onset of respiratory insufficiency is unusual for this condition as only one case of SEPN1-RM presenting as cor pulmonale at the age of 26 years has previously been reported. 15 In our cohort, there was no clear progressive deterioration of respiratory function following the introduction of nocturnal NIV, and FVC values were found to be essentially stable after the second decade of life. Our data also confirm that heart function is usually not altered in SEPN1-RM patients; in a few cases we found evidence of mild right ventricular hypertrophy or mild pulmonary hypertension, likely secondary to the respiratory insufficiency, which improved following commencing NIV. [2] [3] [4] 13, 19 Weight was below the third centile in 57% of the patients in whom accurate measurements were available. This is in keeping with similar previous findings, 4 suggesting that this is a core feature, despite there being no obvious swallowing or chewing difficulties. This aspect should be considered in the longterm management as gastrostomy is only rarely necessary but supplementary food could be offered to maintain weight, if appropriate. Conversely, 3/34 cases (9%) were obese, but this did not have any effect on the severity of their disease. 5 We found no clear correlation between the clinical features and the main muscle pathology findings; the distribution of the various histopathologic subtypes largely reflects that previously described. 2, 4, 5, 13, 16 We also did not observe a clear genotype and phenotype correlation. There was an equal distribution of patients carrying homozygous and compound heterozygous mutations, with 14 novel SEPN1 mutations (table e-1). The c.943 GϾA mutation described earlier 4, 7, 19 was observed in 11 patients, suggesting that this could be a founder mutation.
Our study expands the spectrum of clinical findings associated with SEPN1 mutations, both regarding the range of severity of the disease and age at onset and the long-term functional outcome. Our study suggests that the course of motor function is essentially stable in the majority of patients, although in 15% of cases there was a clear progression of weakness and functional disability. Furthermore, this study expands the spectrum of respiratory involvement as, in 3 cases, respiratory insufficiency was already present in the first years of life while, at the other end of the spectrum, we found patients who only required nocturnal NIV in the fourth decade.
Our results also confirmed that initiation of nocturnal NIV is very effective and that NIV was invariably required only at night.
One of the limitations of the study is that the data were not prospectively collected. Nevertheless, the large number of cases and their wide age range is an important step forward in defining the natural history of SEPN1-RM. This provides valuable information for counseling patients and for improving management and standards of care, but also provides useful information on the progression of this disorder, which may be used for future clinical trials, as drugs such as N-acetylcysteine, able to protect patient cells from oxidative stress-induced cell death, are considered for clinical trials. 14, 15 
